The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.00
Bid: 39.00
Ask: 41.00
Change: 5.00 (14.29%)
Spread: 2.00 (5.128%)
Open: 35.00
High: 40.50
Low: 35.00
Prev. Close: 35.00
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: CleanTech raises GBP520,000 in open offer

Thu, 14th Dec 2023 20:20

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Sareum Holdings PLC - Cambridge, England-based pharmaceutical company, focused on developing kinase inhibitors to treat autoimmune diseases and cancer - Says it is optimistic about its pipeline, as its focus remains on advancing its SDC-1801 therapy. Notes that it expects to receive full safety data for SDC-1801 in the first half of 2024. Says it intends to begin a phase 2 study, which will be completed by the end of 2024.

----------

Ethernity Networks Ltd - Israel-based supplier of data processing semiconductor technology for networking appliances - Says it has received a request from 5G Innovation Leaders Fund LLC to issue 61.5 million new shares pursuant to its settlement deed. In November, it issued 44.9 million shares. Says that following the issue, it will have completed its obligations. Says the new shares to be admitted will represent 21% of its issued capital.

----------

Ashoka WhiteOak Emerging Markets Trust PLC - investment trust focused on global emerging markets - Says net asset value total return for period from its IPO in May to September 30 was 2.60%, outperforming its MSCI Emerging Markets Net Return Sterling by 1.2%. Notes that its share price is performing at a 2.2% premium to NAV. Notes that its key drivers of growth were Senco Gold, Gokaldas Exports and DBS Group. Chair Martin Shenfield says: "We are delighted to present our initial Interim Report covering the period to 30 September 2023 which included the company's successful listing on the London Stock Exchange, a landmark IPO for the sector considering the significant drought of new listings in recent years. We retain the conviction outlined at the company's IPO that the investment case for emerging markets remains attractive and that the company's bottom-up investment strategy provides a highly differentiated approach to accessing this key investment theme with the objective of generating outperformance over the long term."

----------

Digital 9 Infrastructure PLC - invests in internet infrastructure, such as data centres and subsea fibre - Says it has appointed Charlotte Valeur as its interim chair. Notes that its sale of Verne Global is on track to be completed by the end of the first quarter of 2024. Valeur comments: "We remain committed to completing the sale of Verne Global and expediting the strategic review to further maximise shareholder value".

----------

CleanTech Lithium PLC - Chile-focused lithium exploration and development - Says its open offer closed for acceptances oversubscribed by 13% at GBP586,000. Notes it was required to scale back its valid applications to its maximum allowance of 2.4 million, raising a total of GBP520,000. Says it has raised a total of GBP8.5 million from its open offer and fundraising programme. Chief Executive Aldo Boitano says: "Thank you to all our shareholders who participated in the recent open offer and to those who voted at our general meeting. It is encouraging to see an active investor base and your continued support is much appreciated as we develop sustainable lithium projects in Chile. I am particularly pleased that our open offer was oversubscribed, a clear vote of confidence for the company's plans in 2024."

----------

By Harvey Dorset, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
26 Feb 2014 12:01

Sareum Shares Drop As Pretax Loss Widens

LONDON (Alliance News) - Shares in Sareum Holdings PLC slid 12% Wednesday as its pretax loss widened in the half-year ended December 31, 2013. The specialist cancer drug discovery and development business posted a pretax loss of GBP375,000, widened from GBP305,000 in the previous year, due

Read more
22 Jan 2014 10:27

Sareum Receives Patent As It Progresses Cancer Treatment To Trials

LONDON (Alliance News) - Sareum Holdings PLC said Wednesday that it had received a patent from the US Patent and Trademark Office for one of the inventions associated to its CHK1 cancer treatment programme. The patent covers compounds developed by Sareum and Cancer Research UK-funded scient

Read more
2 Dec 2013 14:17

Sareum Holdings does cancer drug deal in China

Cancer drug developer Sareum Holdings has signed a deal with a Chinese medical university to progress its Aurora+FLT3 cancer programme. Sareum has granted the Hebei Medical University Biomedical Engineering Center exclusive rights to carry out pre-clinical and clinical studies within Greater China

Read more
1 Nov 2013 12:52

UK WINNERS & LOSERS: Vodafone Up But Meggitt Slides After Warning

Read more
1 Nov 2013 12:34

Sareum raises funds for further drug development

Sareum Holdings, a cancer drug discovery and development business, has placed 278.5m shares at 0.6p each, it announced Friday. The group raised a conditional £1.67m before expenses from the placing, which it said was oversubscribed. The proceeds of the placing will provide funds to facilitate the

Read more
1 Nov 2013 10:48

CORRECT: Sareum Slides After Placing To Raise Funds For Development Programmes

Read more
1 Nov 2013 10:17

Sareum Slides After Placing To Raise Funds For Development Programmes

Read more
24 Sep 2013 07:35

Sareum Holdings In Co-Development Deal For Cancer Treatment

Read more
22 Apr 2013 08:06

Sareum Holdings and SRI International develop drug for inflammatory diseases

Cancer drug discovery business Sareum Holdings has entered into a co-development agreement with research institute SRI International. The two have joined forces to advance Sareum's Tyrosine Kinase 2 (TYK2) small molecule drug discovery programme for readiness in human clinical trials. Research wi

Read more
18 Feb 2013 08:21

Sareum shares fall following interims and research update

Shares in AIM-listed Sareum Holdings, the specialist cancer drug discovery business, fell sharply on Monday morning after the company unveiled its half yearly results alongside a research update. Cash at bank as of December 31st fell 28% to £380,000 and the company reported a loss on ordinary activ

Read more
7 Feb 2013 08:27

Sareum share price climbs on US patent grant announcement

The share price of AIM-listed specialist cancer drug discovery business Sareum Holdings jumped sharply on Thursday after the company announced that a patent was due to be awarded in the US for one of its key drug discovery inventions. The patent, which is expected on February 19th, relates to compo

Read more
12 Dec 2012 10:40

Sareum share price plummets ahead of AGM

The likelihood that specialist cancer drug discovery business Sareum will conclude a deal to commercialise a research programme this year has fallen, according to an announcement made ahead of its annual general meeting (AGM) on Wednesday morning. During the AGM, Dr. Paul Harper, the company's Chai

Read more
10 Sep 2012 14:37

Small caps round-up: Sareum, Lonrho, FFastFill

Sareum, a specialist cancer drug discovery business, has entered into a four million pound Standby Equity Distribution Agreement (SEDA) with YA Global Master, an investment fund to provide a flexible source of future funding to the company to support its on-going drug research activities. It will a

Read more
7 Aug 2012 11:25

Small caps round-up: YouGov, Sareum and InterQuest...

Environmental Recycling Technologies, which owns the rights to the Powder Impression Moulding (PIM) process which is capable of converting mixed waste plastics into commercially viable products, has confirmed that its US parent application, entitled 'Process for Forming Plastic, Apparatuses for Form

Read more
19 Jul 2012 12:07

Small caps round-up: Byotrol, sareum, KDD ...

Byotrol, an anti-microbial hygiene company, has continued to make progress and has maintained the momentum seen in the second half of last year into the current financial year. The balance sheet continues to remain strong and is well positioned to its objective of positive cash generation at the ear

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.